Boston Scientific (BSX) Tops Q2 EPS by 4 cents; raises EPS guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.53, $0.04 better than the analyst estimate of $0.49. Revenue for the quarter came in at $3.6 billion versus the consensus estimate of $3.5 billion.
GUIDANCE:
Boston Scientific sees Q3 2023 EPS of $0.46-$0.48, versus the consensus of $0.48.
Boston Scientific sees FY2023 EPS of $1.96-$2.00, versus the consensus of $1.95.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Upland Software (UPLD) Tops Q3 EPS by 11c ; Offers Guidance
- Figma (FIG) Tops Q3 EPS by 5c, Offers Guidance
- Atmos Energy (ATO) Tops Q4 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
